Taysha Gene Therapies Inc
NASDAQ:TSHA
Taysha Gene Therapies Inc
NASDAQ:TSHA
Price:
4.57
USD
-2.14%
Market Cap:
$1.3B
Income Statement
Earnings Waterfall
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
Income Statement
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
4
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
7
+188%
|
10
+33%
|
14
+49%
|
15
+8%
|
14
-8%
|
13
-9%
|
10
-23%
|
8
-16%
|
7
-13%
|
8
+12%
|
6
-22%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(106)
|
(142)
|
(173)
|
(191)
|
(183)
|
(158)
|
(129)
|
(138)
|
(130)
|
(89)
|
(87)
|
(96)
|
(92)
|
(92)
|
(95)
|
(96)
|
(102)
|
(108)
|
|
| Selling, General & Administrative |
(28)
|
(36)
|
(41)
|
(45)
|
(44)
|
(42)
|
(37)
|
(35)
|
(31)
|
(31)
|
(30)
|
(28)
|
(30)
|
(29)
|
(29)
|
(30)
|
(31)
|
(32)
|
|
| Research & Development |
(78)
|
(106)
|
(132)
|
(146)
|
(139)
|
(116)
|
(91)
|
(67)
|
(63)
|
(58)
|
(57)
|
(65)
|
(60)
|
(63)
|
(66)
|
(61)
|
(66)
|
(77)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(36)
|
(36)
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
(5)
|
(5)
|
0
|
|
| Operating Income |
(106)
N/A
|
(142)
-34%
|
(173)
-22%
|
(191)
-10%
|
(183)
+4%
|
(158)
+14%
|
(126)
+20%
|
(131)
-4%
|
(121)
+8%
|
(74)
+38%
|
(71)
+4%
|
(82)
-14%
|
(80)
+3%
|
(82)
-4%
|
(87)
-5%
|
(89)
-2%
|
(94)
-6%
|
(102)
-9%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(3)
|
(1)
|
1
|
4
|
6
|
7
|
6
|
7
|
8
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(36)
|
0
|
0
|
(37)
|
(2)
|
0
|
0
|
(7)
|
(5)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(101)
|
(36)
|
(38)
|
(39)
|
60
|
(5)
|
(5)
|
(6)
|
(6)
|
|
| Pre-Tax Income |
(106)
N/A
|
(142)
-34%
|
(175)
-23%
|
(193)
-10%
|
(186)
+4%
|
(161)
+13%
|
(166)
-3%
|
(134)
+19%
|
(124)
+7%
|
(215)
-73%
|
(112)
+48%
|
(118)
-6%
|
(114)
+3%
|
(23)
+80%
|
(89)
-292%
|
(87)
+3%
|
(93)
-7%
|
(100)
-8%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(106)
|
(142)
|
(175)
|
(193)
|
(186)
|
(161)
|
(166)
|
(134)
|
(124)
|
(215)
|
(112)
|
(118)
|
(114)
|
(23)
|
(89)
|
(87)
|
(93)
|
(100)
|
|
| Net Income (Common) |
(106)
N/A
|
(142)
-34%
|
(175)
-23%
|
(193)
-10%
|
(186)
+4%
|
(161)
+13%
|
(166)
-3%
|
(134)
+19%
|
(124)
+7%
|
(215)
-73%
|
(112)
+48%
|
(118)
-6%
|
(114)
+3%
|
(23)
+80%
|
(89)
-292%
|
(87)
+3%
|
(93)
-7%
|
(100)
-8%
|
|
| EPS (Diluted) |
-2.83
N/A
|
-3.74
-32%
|
-4.64
-24%
|
-5.05
-9%
|
-4.63
+8%
|
-3.94
+15%
|
-3.78
+4%
|
-2.11
+44%
|
-1.93
+9%
|
-1.71
+11%
|
-0.96
+44%
|
-0.51
+47%
|
-0.49
+4%
|
-0.08
+84%
|
-0.36
-350%
|
-0.34
+6%
|
-0.31
+9%
|
-0.28
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
